Australia MedTech Market Overview 2023-2028
IMARC Group, a leading market research company, has recently releases report titled “Australia MedTech Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the Australia MedTech market size, share, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
The Australia MedTech market size reached US$ 7.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 11.1 Billion by 2028, exhibiting a growth rate (CAGR) of 6.7% during 2023-2028.
MedTech, short for medical technology, encompasses a diverse range of cutting-edge solutions and devices crafted to enhance healthcare delivery and elevate patient outcomes. Its primary goals include refining diagnostic precision, optimizing treatment effectiveness, and elevating overall patient care. MedTech plays a pivotal role in tackling diverse medical challenges and streamlining healthcare procedures. With its contribution to enhancing both patient and healthcare provider experiences, there is a growing demand for MedTech in Australia.
Request a Sample Report:– https://www.imarcgroup.com/australia-medtech-market/requestsample
Australia MedTech Market Trends and Drivers:
Currently, the escalating desire for non-invasive and personalized healthcare solutions is a significant driver of market growth in Australia. This is underscored by the increasing incidence of chronic diseases among the population, further fueling market expansion. The demand for medical technologies facilitating early diagnosis, continuous monitoring, and targeted treatments is on the rise, contributing to a positive market outlook in the country. The emphasis on proactive and individualized approaches is also playing a crucial role in fostering market growth. Additionally, the advent of innovative medical devices and digital health platforms tailored to specific medical conditions is driving market expansion. Furthermore, the heightened focus on patient-centric approaches is a key force propelling market growth in Australia.
Australia MedTech Market 2023-2028 Analysis and Segmentation:
Top Key Players covered in this report are: Alcidion Group Limited, Anatomics Pty Ltd, Artrya, AusBiotech, Avanade Australia (Accenture), Cochlear Limited, Ellex, ResMed Inc., Schott AG and Sirtex Medical Limited
The report segmented the market on the basis of region, type, component, deployment type, application and end user.
Breakup by Type:
- Telehealth
- Medical Wearables
- EMR/EHR Systems
- Medical Apps
- Healthcare Analytics
- Others
Breakup by Component:
- Software
- Hardware
- Service
Breakup by Deployment Type:
- On-Premises
- Cloud-Based
Breakup by Application:
- Cardiology
- Diabetes
- Neurology
- Sleep Apnea
- Oncology
- Others
Breakup by End User:
- Healthcare Providers
- Healthcare Payers
- Pharmaceutical Companies
Breakup by Region:
- Western Australia
- New South Wales
- Queensland
- Victoria
- Rest of Australia
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023- 2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
134 N 4th St. Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800